Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURANDOT: Abciximab + Thrombectomy vs Alteplase in Stroke
NCT02016547Phase 4Terminated
- Sponsor
- SOS Attaque Cérébrale
- Start
- Sep 2013
- Primary completion
- Feb 2015
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in ischemic stroke, sponsored by SOS Attaque Cérébrale. Started Sep 2013; status: terminated.
02
Drugs
abciximab
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02016547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016547.